JMS Co.,Ltd. Announces Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Earnings Guidance for the Six Months Ending September 30, 2018 and Full Year Ending March 31, 2019; Announces Dividend for the Year Ended March 31, 2018, Payable on June 22, 2018; Provides Dividend Guidance for the Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2019
May 17, 2018
Share
JMS Co.,Ltd. announced consolidated earnings results for the year ended March 31, 2018. For the year, the company reported net sales of ¥56,520 million against ¥55,574 million a year ago. Operating income was ¥573 million against ¥1,106 million a year ago. Ordinary profit was ¥820 million against ¥1,451 million a year ago. Profit attributable to owners of parent was ¥631 million or ¥25.91 per basic share against ¥1,182 million or ¥48.51 per basic share a year ago. Cash flows from operating activities was ¥2,666 million against ¥4,675 million a year ago. Profit before income taxes was ¥740 million against ¥1,100 million a year ago. Purchase of property, plant and equipment was ¥2,800 million against ¥4,744 million a year ago. Purchase of intangible assets was ¥136 million against ¥98 million a year ago. Rate of return on equity was 2.0% against 3.8% a year ago.
The company announced year-end dividend of ¥8.00 per share for the period ended March 31, 2018. The dividend will be paid on June 22, 2018.
The company provided dividend guidance for the second quarter ending September 30, 2018 and full year ending March 31, 2019. For the quarter, the company expects dividend of ¥8.00 per share compared to ¥4.00 per share paid in the same period a year ago.
For the full year ending March 31, 2019, the company expects dividend of ¥8.00 per share and total dividend of ¥16.00 per share.
The company provided consolidated earnings guidance for the six months ending September 30, 2018 and full year ending March 31, 2019. For the six months ending September 30, 2018, the company expects net sales of ¥28,000 million, ordinary income of ¥350 million, ordinary profit of ¥450 million and profit attributable to owners of parent of ¥300 million or ¥12.31 per share.
For the full year ending March 31, 2019, the company expects net sales of ¥58,000 million, ordinary income of ¥1,000 million, ordinary profit of ¥1,200 million and profit attributable to owners of parent of ¥800 million or ¥32.83 per share.
JMS CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical equipment and drugs. The Company operates through five geographical segments including Japan, Singapore, China, Philippines and Germany. The Company is engaged in the manufacture and sale of infusion and nutrition products, dialysis products, surgery products, blood and cell products and other products. The Companyâs main products include infusion & transfusion set, syringe pump, surgical gown, dialysis kit, peritoneal dialysate, microcatheter, blood bag, among others. The Company is also involved in the provision of maintenance service and other related services.
JMS Co.,Ltd. Announces Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Earnings Guidance for the Six Months Ending September 30, 2018 and Full Year Ending March 31, 2019; Announces Dividend for the Year Ended March 31, 2018, Payable on June 22, 2018; Provides Dividend Guidance for the Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2019